Literature DB >> 10960455

Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma.

C A Schirren1, M C Jung, J T Gerlach, T Worzfeld, G Baretton, M Mamin, N Hubert Gruener, M Houghton, G R Pape.   

Abstract

Virus-specific CD4(+) T-cell response at the site of inflammation is believed to play a decisive role for the course of viral disease. In hepatitis C virus (HCV) infection, the majority of studies focused on the peripheral blood T-cell response. In this study we analyzed intrahepatic virus-specific CD4(+) T-cell response and compared this with that in the peripheral blood. Liver and blood-derived T-cell lines were studied in 36 patients (18 with chronic hepatitis C and 18 with HCV-associated cirrhosis). Virus-specific interferon gamma (IFN-gamma) production at a single cell level to various HCV-proteins (core, nonstructural [NS] 3/4, NS5) were determined by enzyme-linked immunospot (ELIspot). Phenotyping was done by fluorescent-activated cell sorter analysis. In approximately half (16 of 36 [44%]) of intrahepatic T-cell lines a significant number of IFN-gamma spots were observed, whereas this was the case in only 19% (7 of 36 T-cell lines) in the blood. In relative terms, core and nonstructural proteins were recognized with the same frequency in both compartments, but HCV-specificity was significantly more often detected in liver tissue compared with the blood. Hepatitis activity index, viral load, and alanine transaminase levels did not correlate with the detection of HCV-specific CD4(+) T cells. All T-cell lines were dominated by CD4(+) T cells. In conclusion, HCV-specific CD4(+) T cells are multispecific, compartmentalize to the liver, and produce IFN-gamma. We speculate that our data would support the concept of compartmentalization of specific T cells at the site of inflammation and that a low frequency of specific T cells is associated with failure to clear the virus and a chronic course of disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960455     DOI: 10.1053/jhep.2000.9635

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

1.  Identification of the epitopes on HCV core protein recognized by HLA-A2 restricted cytotoxic T lymphocytes.

Authors:  H C Zhou; D Z Xu; X P Wang; J X Zhang; Y Huang; Y P Yan; Y Zhu; B Q Jin
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Exposure to low infective doses of HCV induces cellular immune responses without consistently detectable viremia or seroconversion in chimpanzees.

Authors:  Mohamed Tarek Shata; Nancy Tricoche; Marion Perkus; Darley Tom; Betsy Brotman; Patricia McCormack; Wolfram Pfahler; Dong-Hun Lee; Leslie H Tobler; Michael Busch; Alfred M Prince
Journal:  Virology       Date:  2003-09-30       Impact factor: 3.616

Review 3.  Adaptive immunity to the hepatitis C virus.

Authors:  Christopher M Walker
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

Review 4.  Immune mechanisms of vaccine induced protection against chronic hepatitis C virus infection in chimpanzees.

Authors:  Babs E Verstrepen; André Boonstra; Gerrit Koopman
Journal:  World J Hepatol       Date:  2015-01-27

5.  Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells.

Authors:  Stephen M Brindley; Allison M Lanham; Frederick M Karrer; Rebecca M Tucker; Andrew P Fontenot; Cara L Mack
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

6.  Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection.

Authors:  Camilla S Graham; Annalee Wells; Tun Liu; Kenneth E Sherman; Marion Peters; Raymond T Chung; Atul K Bhan; Janet Andersen; Margaret James Koziel
Journal:  AIDS       Date:  2005-05-20       Impact factor: 4.177

Review 7.  Alloimmunity and autoimmunity in chronic rejection.

Authors:  Anil Seetharam; Venkataswarup Tiriveedhi; T Mohanakumar
Journal:  Curr Opin Organ Transplant       Date:  2010-08       Impact factor: 2.640

Review 8.  CD4+ T cell responses in hepatitis C virus infection.

Authors:  Nasser Semmo; Paul Klenerman
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

Review 9.  Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.

Authors:  Nataraju Angaswamy; Venkataswarup Tiriveedhi; Nayan J Sarma; Vijay Subramanian; Christina Klein; Jason Wellen; Surendra Shenoy; William C Chapman; T Mohanakumar
Journal:  Hum Immunol       Date:  2013-07-19       Impact factor: 2.850

10.  Characterization of virus-specific T-cell immunity in liver allograft recipients with HCV-induced cirrhosis.

Authors:  A Bharat; F Barros; K Narayanan; B Borg; M Lisker-Melman; S Shenoy; J Lowell; J Crippin; W Chapman; T Mohanakumar
Journal:  Am J Transplant       Date:  2008-06       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.